Top 81 Contractors in NAICS 325411: Medicinal and Botanical Manufacturing, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 100% of FY2021 NAICS 325411 contract dollars

Ranking facts

Contract obligations
$3,543,103,624 Net of deobligations, by contracts coded NAICS 325411
Contractors
92 Parent companies with an obligation
Largest contractor
Mckesson Corporation $2.97 billion, 83.7% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 81 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $2,967,010,497
Rank history: #1 in FY2022, #3 in FY2023, #64 in FY2024 and #39 in FY2025; unchanged since FY2020.
2 $463,826,453
Rank history: #2 in FY2022, #2 in FY2023, #1 in FY2024 and #1 in FY2025; up 1 since FY2020.
3 $58,477,513
Rank history: #3 in FY2022, #4 in FY2023, #3 in FY2024 and #3 in FY2025; up 2 since FY2020.
4 $23,855,151
Rank history: #5 in FY2022, #7 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2020.
5 $4,427,118
Rank history: #6 in FY2022, #6 in FY2023, #5 in FY2024 and #4 in FY2025; up 3 since FY2020.
6 $3,890,243
Rank history: not on the FY2022–FY2023 lists, #4 in FY2024 and #2 in FY2025; new, not ranked in FY2020.
7 $3,193,438
Rank history: #8 in FY2022, #8 in FY2023, #8 in FY2024 and #7 in FY2025; up 2 since FY2020.
8 $2,901,856
Rank history: #10 in FY2022, #9 in FY2023, #9 in FY2024 and #5 in FY2025; up 4 since FY2020.
9 $2,400,046
Rank history: #14 in FY2022, #52 in FY2023 and not on the FY2024–FY2025 lists; up 73 since FY2020.
10 $2,247,194
Rank history: #7 in FY2022, not on the FY2023 list, #6 in FY2024 and #16 in FY2025; up 3 since FY2020.
11 $1,692,489
Rank history: #16 in FY2022, #12 in FY2023, #11 in FY2024 and #13 in FY2025; down 5 since FY2020.
12
Albany Molecular Research Inc. Through Curia Global Inc.
$1,273,505
Rank history: #34 in FY2022 and not on the FY2023–FY2025 lists; down 2 since FY2020.
13 $1,263,169
Rank history: #15 in FY2022 and not on the FY2023–FY2025 lists; up 13 since FY2020.
14 $759,985
Rank history: #37 in FY2022, #10 in FY2023, #12 in FY2024 and not on the FY2025 list; up 4 since FY2020.
15
Sagent Pharmaceuticals Inc.
$670,331
Rank history: #19 in FY2022, #26 in FY2023, #27 in FY2024 and #31 in FY2025; up 19 since FY2020.
16 $588,328
Rank history: #17 in FY2022, #11 in FY2023, #30 in FY2024 and #19 in FY2025; down 9 since FY2020.
17 $486,147
Rank history: #23 in FY2022, #13 in FY2023, #18 in FY2024 and #11 in FY2025; up 4 since FY2020.
18 $480,670
Rank history: not on the FY2022–FY2023 lists, #13 in FY2024 and #10 in FY2025; up 34 since FY2020.
19 $413,772
Rank history: #24 in FY2022, #24 in FY2023, #22 in FY2024 and #8 in FY2025; up 14 since FY2020.
20 $410,835
Rank history: #32 in FY2022, #19 in FY2023, #26 in FY2024 and #20 in FY2025; up 10 since FY2020.
21 $340,228
Rank history: #11 in FY2022, #17 in FY2023, #19 in FY2024 and #21 in FY2025; up 8 since FY2020.
22
Hikma Pharmaceuticals PLC Through Hikma Pharmaceuticals USA Inc.
$299,701
Rank history: #13 in FY2022, #22 in FY2023, #63 in FY2024 and not on the FY2025 list; up 87 since FY2020.
23 $231,981
Rank history: #31 in FY2022, #27 in FY2023, #29 in FY2024 and #27 in FY2025; up 19 since FY2020.
24
Cortec Group Inc. Through The Hygenic Corporation
$213,991
Rank history: #29 in FY2022 and not on the FY2023–FY2025 lists; up 1 since FY2020.
25 $212,402
Rank history: #30 in FY2022, #25 in FY2023, #28 in FY2024 and #24 in FY2025; up 3 since FY2020.
26 $207,500
Rank history: #22 in FY2022 and not on the FY2023–FY2025 lists; down 15 since FY2020.
27
Allergan Inc. 2 awardees, including Allergan USA Inc.
$181,403
Rank history: not on the FY2022–FY2025 lists; unchanged since FY2020.
28 $167,098
Rank history: not on the FY2022–FY2025 lists; up 22 since FY2020.
29 $148,384
Rank history: #26 in FY2022, #20 in FY2023, #21 in FY2024 and #15 in FY2025; up 28 since FY2020.
30
Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG Through Heyltex Corporation
$148,317
Rank history: #58 in FY2022 and not on the FY2023–FY2025 lists; up 2 since FY2020.
31 $127,364
Rank history: not on the FY2022 list, #23 in FY2023 and not on the FY2024–FY2025 lists; down 16 since FY2020.
32 $113,259
Rank history: #33 in FY2022 and not on the FY2023–FY2025 lists; up 63 since FY2020.
33 $103,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
34 $87,457
Rank history: #25 in FY2022, #15 in FY2023, #14 in FY2024 and #18 in FY2025; new, not ranked in FY2020.
35 $83,904
Rank history: #21 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
36 $74,341
Rank history: #27 in FY2022, #31 in FY2023, #36 in FY2024 and #17 in FY2025; up 72 since FY2020.
37
Accredo Health Group Inc. Through Priority Healthcare Distribution Inc.
$63,120
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
38 $53,111
Rank history: #44 in FY2022, #41 in FY2023 and not on the FY2024–FY2025 lists; up 20 since FY2020.
39 $52,627
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
40 $47,254
Rank history: #61 in FY2022 and not on the FY2023–FY2025 lists; up 5 since FY2020.
41 $46,486
Rank history: #41 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
42 $44,663
Rank history: #46 in FY2022, #42 in FY2023, #44 in FY2024 and #40 in FY2025; up 68 since FY2020.
43
Central Admixture Pharmacy Services Inc.
$43,500
Rank history: not on the FY2022–FY2025 lists; down 19 since FY2020.
44
Regents of the University of Minnesota
$39,519
Rank history: not on the FY2022–FY2025 lists; down 30 since FY2020.
45 $35,824
Rank history: #59 in FY2022 and not on the FY2023–FY2025 lists; down 5 since FY2020.
46 $31,049
Rank history: #40 in FY2022, #38 in FY2023, #35 in FY2024 and #34 in FY2025; up 41 since FY2020.
47
Avkare LLC 2 awardees
$30,708
Rank history: #64 in FY2022, #43 in FY2023, #39 in FY2024 and #36 in FY2025; up 15 since FY2020.
48
American Tokyo Kasei Inc.
$25,276
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
49 $24,905
Rank history: #47 in FY2022, #54 in FY2023, #47 in FY2024 and #38 in FY2025; up 18 since FY2020.
50 $24,529
Rank history: not on the FY2022–FY2025 lists; up 64 since FY2020.
51 $24,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
52 $21,234
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
53 $20,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
54 $19,800
Rank history: not on the FY2022–FY2023 lists, #53 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
55 $18,841
Rank history: #68 in FY2022, #61 in FY2023, not on the FY2024 list and #64 in FY2025; new, not ranked in FY2020.
56 $18,800
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
57
Xellia Pharmaceuticals USA LLC
$17,792
Rank history: #12 in FY2022, #59 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
58 $16,876
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
59
Baxter International Inc. Through Baxter Healthcare Corporation
$15,639
Rank history: #20 in FY2022, #14 in FY2023, #48 in FY2024 and not on the FY2025 list; down 39 since FY2020.
60 $14,738
Rank history: #28 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
61 $13,530
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
62 $10,230
Rank history: #48 in FY2022, #56 in FY2023, #34 in FY2024 and not on the FY2025 list; up 31 since FY2020.
63
Seocal Incorporated
$10,075
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
64 $9,901
Rank history: #56 in FY2022 and not on the FY2023–FY2025 lists; up 24 since FY2020.
65 $9,240
Rank history: not on the FY2022 list, #5 in FY2023 and not on the FY2024–FY2025 lists; down 46 since FY2020.
66 $8,312
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
67 $5,175
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
68 $2,475
Rank history: #71 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
69 $2,284
Rank history: not on the FY2022–FY2025 lists; up 10 since FY2020.
70
Alcon Vision LLC
$1,509
Rank history: #45 in FY2022, #34 in FY2023, #38 in FY2024 and #37 in FY2025; new, not ranked in FY2020.
71 $1,256
Rank history: #73 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
72
Alvogen Group Inc. Through Alvogen, Inc.
$1,049
Rank history: #63 in FY2022, not on the FY2023 list, #69 in FY2024 and not on the FY2025 list; down 6 since FY2020.
73 $953
Rank history: #76 in FY2022 and not on the FY2023–FY2025 lists; up 3 since FY2020.
74 $827
Rank history: not on the FY2022–FY2025 lists; down 21 since FY2020.
75 $721
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
76
Astrazeneca PLC Through Astrazeneca Pharmaceuticals LP
$500
Rank history: #75 in FY2022, #64 in FY2023, #73 in FY2024 and not on the FY2025 list; up 37 since FY2020.
77 $433
Rank history: not on the FY2022–FY2023 lists, #70 in FY2024 and #55 in FY2025; up 35 since FY2020.
78 $191
Rank history: #72 in FY2022 and not on the FY2023–FY2025 lists; up 37 since FY2020.
79 $155
Rank history: #79 in FY2022 and not on the FY2023–FY2025 lists; up 38 since FY2020.
80 $30
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
81 $20
Rank history: #78 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
Show 56 more

81 of 92 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $3.55 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325411 contractors in FY2021?

1. Mckesson Corporation ($2.97B), 2. Cencora, Inc. ($464M), 3. DMS Pharmaceutical Group Inc. ($58.5M), 4. Amerisourcebergen Drug Corp ($23.9M), 5. Cardinal Health, Inc. ($4.43M), 6. Emergent Biosolutions Inc. ($3.89M), 7. Phoenix Textile Corporation ($3.19M), 8. Fresenius Kabi LLC ($2.9M), 9. Akorn, Inc. ($2.4M), 10. Patterson Companies, Inc. ($2.25M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work